Skip to main content
HR 2009 115th Congress House

Fostering Innovation in Medical Imaging Act of 2017

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents.

Introduced: April 28, 2017 See on congress.gov
Health Drug safety, medical device, and laboratory regulationHealth technology, devices, suppliesMedical tests and diagnostic methodsRadiation
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 7, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Fostering Innovation in Medical Imaging Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve a medical imaging device intended to be used with an approved contrast agent when—under specified conditions—the use differs from the approved use of the contrast agent. (Contrast agents are substances used to enhance the visibility of body structures in medical imaging.) The FDA center that reviews medical devices has primary jurisdiction over such reviews.

After authorization of a medical imaging device that makes new use of a contrast agent, the sponsor of the approved contrast agent may submit a supplemental application for the new use of the contrast agent.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Democratic 2
D
DelBene, Suzan K.
Washington · Apr 28, 2017
 D
Peters, Scott H.
California · Apr 6, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2009: Fostering Innovation in Medical Imaging Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2009/
MLA
"H.R. 2009: Fostering Innovation in Medical Imaging Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2009/.
Bluebook (legal)
H.R. 2009, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2009/.
Markdown link
[H.R. 2009: Fostering Innovation in Medical Imaging Act of 2017](https://openamerica.io/bill/115-HR-2009/)
Report a problem